Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found five records

$50,000.00

Apr 10, 2026

For-profit organization

Agreement:

600074107

Agreement Number:

600074107

Duration: from Apr 10, 2026 to Dec 31, 2027
Description:

Marketing strategy: The project aims to increase the sales of a company specializing in designing medical device technology.

Organization: Canada Economic Development for Quebec Regions
Program Name: REGI - Commercialization and exportation
Location: Montréal, Quebec, CA H4A 2T7

$197,000.00

May 26, 2025

For-profit organization

Agreement:

Scale-up of a medical technology to treat breast cancer and its preclinical validation to treat breast cancer and skin cancer.

Agreement Number:

1034054

Duration: from May 26, 2025 to Mar 31, 2027
Description:

The project involves the conceptual design of the pre-production applicator and its in vitro testing for breast cancer, followed by the conceptual design of the pre-production control unit.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program
Location: Montreal, Quebec, CA H4A 2T7

$202,810.00

Jun 1, 2021

For-profit organization

Agreement:

Validation of a unique high precision Cold Plasma Device for breast cancer treatment – Phase 3

Agreement Number:

975628

Duration: from Jun 1, 2021 to Mar 31, 2023
Description:

This project will allow to prepare a unique high precision cold plasma device prototype for breast cancer treatment so it can be authorized by Health Canada for an investigational testing (first-in-human) clinical trial.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H4A 2T7

$119,200.00

Sep 2, 2019

For-profit organization

Agreement:

Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapy Phase 2

Agreement Number:

935250

Duration: from Sep 2, 2019 to Mar 31, 2021
Description:

This project enhances the development of a unique high precision cold plasma device as a adjuvant for breast cancer radiotherapy. More particularly, the detailed design, fabrication and commissioning of this prototype will be performed so that it can be used in clinical trials in Canada.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H4A 2T7

$50,000.00

Apr 2, 2018

For-profit organization

Agreement:

Validation of a unique High Precision Cold Plasma Device as adjuvant for breast cancer radiotherapy

Agreement Number:

905621

Duration: from Apr 2, 2018 to Mar 29, 2019
Description:

This project assesses a unique device as a potential adjuvant for breast cancer radiotherapy to enhance the selective kill of breast cancer cells in order to reduce cancer recurrence.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H4A 2T7